This protocol describes how to create a precise laminectomy for induction of stable transection-type spinal cord injury in the mouse model, with minimal collateral damage for spinal cord injury research.
Spinal cord injury (SCI) largely leads to irreversible and permanent loss of function, most commonly as a result of trauma. Several treatment options, such as cell transplantation methods, are being researched to overcome the debilitating disabilities arising from SCI. Most pre-clinical animal trials are conducted in rodent models of SCI. While rat models of SCI have been widely used, mouse models have received less attention, even though mouse models can have significant advantages over rat models. The small size of mice equates to lower animal maintenance costs than for rats, and the availability of numerous transgenic mouse models is advantageous for many types of studies. Inducing repeatable and precise injury in the animals is the primary challenge for SCI research, which in small rodents requires high-precision surgery. The transection-type injury model has been a commonly used injury model over the last decade for transplantation-based therapeutic research, however a standardized method for inducing a complete transection-type injury in mice does not exist. We have developed a surgical protocol for inducing a complete transection type injury in C57BL/6 mice at thoracic vertebral level 10 (T10). The procedure uses a small tip drill instead of rongeurs to precisely remove the lamina, after which a thin blade with rounded cutting edge is used to induce the spinal cord transection. This method leads to reproducible transection-type injury in small rodents with minimal collateral muscle and bone damage and therefore minimizes confounding factors, specifically where behavioral functional outcomes are analyzed.
Spinal cord injury (SCI) is a complex medical problem that results in drastic changes in health and lifestyle. There is no cure for SCI, and the pathophysiology of SCI is not thoroughly understood. Animal SCI models, in particular rodent models, offer an invaluable tool for trialing new treatments, and have been used to explore SCI for decades. To date, over 72% of pre-clinical SCI studies have employed rat models, as compared to a mere 16% that have used mice1. Although rats, due to their larger size and tendency to form cavities akin to human SCIs, have traditionally been the preferred model animals for studying novel therapeutic approaches, mice (including many transgenic mouse models) are now being used more frequently to study cellular and molecular mechanisms of the SCI2. The mouse model offers additional benefits in terms of easier handling, faster reproductive rates and lower costs than rats; mice also exhibit a high degree of genomic similarity with humans1,2,3. The major disadvantage of the mouse model has been identified as the significantly smaller size that creates challenges for surgical interventions for creating and treating spinal cord injuries4,5.
There is a gap in the existing literature that highlights the need for a robust and reproducible surgical protocol to induce stable SCI in the mouse model. Therefore, we provide a novel and precise surgical approach in this protocol to overcome these limitations. This protocol provides in-depth guidelines to induce a transection-type injury in mice, as this injury type has been recognized to be the most appropriate to study regenerative and degenerative changes following an injury6, as well as neuroplasticity, neural circuitry and tissue engineering approaches7. We have chosen to induce the injury in the lower thoracic region, since thoracic level SCI is used most commonly in the literature1.
All procedures were carried out with the approval of the Griffith University Animal Ethics Committee (ESK/04/16 AEC and MSC/04/18 AEC) under the guidelines of the National Health and Medical Research Council of Australia.
1. Animal set-up procedure for the surgery
2. Laminectomy
3. Transection
4. Closure and immediate post-operative care
5. Evaluation of the injury model
The resulting method as depicted in Figure 1, involves adequate stabilization of the mouse (Figure 1A) and good visualization of the spine and paraspinous tissue (Figure 1B). Spinous process and laminae can be clearly visualized with minimal muscle dissection and blood loss (Figure 1C, highlighted zone). The fine tip drilling is performed as shown in Figure 1D, to create a laminectomy window as shown by the rectangle. The resulting laminectomy window is clear and allows direct visualization and access to the spinal cord (Figure 1E, highlighted zone). The schematic concept of this process is explained in Figure 1F. The narrow transection blade can easily fit through the discrete laminectomy window (Figure 1G) and in a smooth swiping motion, a complete transection type injury can be created (Figure 1H–I). Thus, this method causes minimal muscle dissection, minimal collateral bone damage, and results in a stable complete transection type injury with minimal blood loss. Despite the induction of severe SCI in the animals, the surgical procedure and post-operative care resulted in high survival rates of the animals. All animals reported for this manuscript survived the spinal cord surgery; and subsequent surgeries by our lab have resulted in a survival rate of >99%.
To assess whether this method for inducing transection-type SCI in mice was reproducible and consistent, we analyzed the injured spinal cord using histology/immunohistochemistry and behavioral testing (n = 8 animals) (Figure 2). Immunolabeling against the astrocyte marker glial fibrillary acidic protein (GFAP) demarcated the boundary of the intact spinal cord, with the injury site being the region between the cord stumps when viewed with longitudinal sections (Figure 3A). A consistent-sized defect was induced at the transection site, with an average minimal distance of 550.4 ± 17.3 µm (Figure 3B). Behavioral data deploying the Basso Mouse Scale (BMS)9 of an open field test showed that the injured mice exhibit no hind limb movement after the injury (Figure 3C). This is represented by a score of 0 on the BMS for up to 28 days post-injury. Thus, the protocol produces complete and reliable transection-type injury resulting in complete loss of function below the injury level and does not lead to spontaneous reversal of the paralysis (Figure 3D,E).
Figure 1: Key steps in the transection injury protocol. (A) Animal set up and stabilization prior to surgery. Schematic and photograph from the surgery are both shown. (B) Schematic and photograph showing incision, retractor placement and blunt dissection to expose the deep muscle layers. (C) Stabilization of spine with forceps and exposing laminae of T10 vertebra. The rectangle in the photograph highlights laminae and spinous process of the T10 vertebra. (D) Fine tip drill to perform laminectomy. The rectangle in this photograph traces the laminectomy window. (E) Complete laminectomy window highlighted by the rectangle, within which the spinal cord is clearly visible. (F) Series of schematic drawings showing the drilling concept to perform a complete laminectomy, in a cross-sectional orientation. (G) This photograph depicts the use of a fine blade transection knife to perform the complete transection type injury, and in (H) the complete injury is visible inside the rectangle, as a dark red transverse line across the spinal cord. (I) Schematic showing the overall view of the laminectomy and injury site. Please click here to view a larger version of this figure.
Figure 2: A schematic explaining the vertebral landmark identification for T10. The spinous process of T10 vertebra is one of the most prominent landmarks that can be palpated at the natural curvature of the thoracic spine. At this point the spinous processes change the morphology so that the tips of the spinous processes cranial from T10 point caudally, and the tips of the spinous processes caudal from T10 point cranially. Please click here to view a larger version of this figure.
Figure 3: Representative results from transection type injury induced in C57BL/6 mice. (A) A longitudinal section of the spinal cord reveals the complete transection-type injury.Tissue was imaged on an inverted microscope. Anti-GFAP immunolabelling labels astrocytes (red) while nuclei are labeled with Hoechst 33342 (blue). The injury gap using a linear measurement of the shortest point was 550 µm. Scale bar = 200 µm. IS = injury site, IVD = intervertebral disc, SC = spinal cord, VB = vertebral body. (B) Injury size was measured in 8 animals. The mean injury size was 550.4 ± 17.3 µm with maximum being 577.8 µm and minimum 525.4 µm. (C) Motor behavior scored on Basso Mouse Scale (BMS), which was 9 in all mice prior to the injury and remained at 0 for 4 weeks after the injury, indicating a complete loss of motor function below the injury site (n = 8 mice). (D) Gait of a healthy mouse before the injury. (E) Gait of the same mouse after the injury. Please click here to view a larger version of this figure.
This method induces a complete transection type injury at the T10 vertebral level in mice, which results in complete paraplegia of the animal, below the level of injury. Overall, this method results in minimal bleeding, negligible collateral damage and a stable, reproducible injury. As compared to previously published methods of transection without laminectomy10, this method offers the benefits in terms of direct visualization without manipulating the curvature of the spine, better control over completeness of the injury, and enhanced ability to control bleeding and achieve hemostasis. The advantage of this method is that the protocol can be modified for use at any other vertebral levels other than T10, as well as to perform other injury types such as hemi-sections, partial dorsal transections, dorsal root avulsions, crush and contusions.
A major component of this protocol is that it employs the use of a fine-tip drill. While the use of the drill may require a high skill level and more extensive training, it achieves a clean and complete laminectomy. Another crucial factor is the use of a narrow-bladed knife for transection, instead of micro-scissors. This results in less unwanted collateral damage as compared to using scissors. Conversely, however, if too much lateral pressure is exerted, the blade can cause some injury to the vertebral body. The described protocol may require the surgeon to perform some troubleshooting. If the laminectomy is not performed properly, there may be bone spurs remaining, which can restrict access to the laminectomy window. Inserting one of the prongs of the fine tip forceps can enable the surgeon to grasp and break off any remaining bone spurs. However, care must be taken to not injure the exposed spinal cord in the process. If the laminectomy results in a jagged bone edge, the drilling can be performed again to straighten the laminectomy margin. This may be impractical if the laminectomy window is already wide enough, in which case, the transection should be performed without tampering with the laminectomy site.
It is strongly recommended that the users practice the laminectomy procedures at least 8–10 times at the relevant spinal level in a cadaveric dissection prior to attempting in a live survival surgery. Although, the drill holding and maneuvering techniques are simple, they may require the users to get acquainted with the equipment. Here, we also provide some useful advice to help with spine and hand stabilization during the drilling procedure. If the user is right handed, the spine should be stabilized by using the curved forceps with the left hand so that the forceps approach the spine from the cranial aspect. This keeps the caudal aspect of the spine clear to approach with the drill held in the right (or the predominant) hand. The drill should be held with a pincer grip between thumb, index and middle fingers. The hand should be well supported along the medial edge of the wrist and the outstretched fifth finger. Keeping the arm completely adducted so that the elbow touches the body may help achieve better control over the drill grip during practice. The drilling action should only involve motion at the fingers holding the drill and not at the wrist, not unlike using a pen for writing.
The authors have nothing to disclose.
This work was supported by a Griffith University International Student (PhD) stipend to RR, a Perry Cross Foundation Grant to JE and JSJ, a Clem Jones Foundation Grant to JSJ and JE, and a Motor Accident Insurance Commission of Queensland grant to JSJ and JE.
Baytril injectable 50 mg/mL, 50 mL | Provet | BAYT I | Post-operative care drug |
Betadine 500 mL | Provet | BETA AS | Consumable |
Castroviejo needle holder, locking | ProSciTech | T149C | Reusable |
Ceramic zirconia blade, round with sharp sides, single edge, angled | ProSciTech | TXD101A-X | Reusable |
Cotton swabs (5pcs) | Multigate | 21-893 | Consumable |
Dremel Micro | DREMEL | 8050-N/18 | Cordless rotary tool |
Dressing forceps fine | Multigate | 06-306 | Single use disposable |
Drill bits | Kemmer Präzision | SM 32 M 0550 070 | Reusable |
Dumont #7b forceps | Fine Science Tools | 11270-20 | Reusable |
Dumont tweezers, style 5 | ProSciTech | T05-822 | Reusable |
Fur trimmer | WAHL | WA9884-312 | Zero Overlap Hair Trimmer |
Iris scissors, Ti, sharp tips, straight, 90mm | ProSciTech | TY-3032 | Reusable |
Isoflurane isothesia NXT 250 | Provet | ISOF 00 HS | Anaesthetic agent |
Colibri Retractor – 4cm | Fine Science Tools | 17000-04 | Reusable |
Scalpel handle | ProSciTech | T133 | Reusable |
Signature latex surgical gloves size 7.5 | Medline | MSG5475 | Consumable |
Sodium Chloride 0.9% | STS | PHA19042005 | Consumable |
Sterile Dressing Pack | Multigate | 08-709 | Single use disposable |
Sterile Fluid Impervious Drape 60×60 cm | Multigate | 29-220 | Single use disposable |
Surgical spirit 100 mL | Provet | # SURG SP | Consumable |
Suture Material – SILK BLK 45CM 5/0 FS-2 | Johnson & Johnson Medical | 682G | Silk Suture |
Suture Material – Vicryl 70CM 5-0 S/A FS-2 | Johnson & Johnson Medical | VCP421H | Vicryl Suture |
Temgesic 0.3 mg in 1 mL, x 5 ampoules (class S8 drug) | Provet | TEMG I | Post-operative care drug |